AbbVie revenue rises 6.2 percent

(Reuters) - AbbVie Inc reported a 6.2 percent rise in quarterly net revenue, helped by demand for its flagship $15 billion-a-year arthritis treatment, Humira.

AbbVie revenue rises 6.2 percent
Read More


Bagikan Berita Ini